IMTTS scientists Dr. Anne Bührke and Anita Pralas proudly represented our FIBREX Team at the ESGCT in Brussels. As the ESGCT is a leading organization in the field of gene and cell therapy, we were excited to join this prestigious event and contribute to the exchange of knowledge and advancements in this rapidly evolving field. The conference brought together experts from various fields of study and demonstrated the translation of innovative research into clinical applications. It included many inspiring talks and panel discussions, which led to an overall fascinating experience. Especially during the Symposium from the European Innovation Council (EIC) Cell and Gene Therapy community, we gained a lot of new insights and perspectives.

Copyright Anita Pralas

We are excited to announce that we have participated at the annual conference of Deutsche Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. (DGK) in Mannheim. This prestigious event brought together leading experts, researchers, and professionals in the field of cardiology providing a platform for knowledge exchange, and discussion of the latest advancements and the most pressing issues in the field. The conference featured a diverse and engaging program including keynote lectures, panel discussions, and networking opportunities. IMTTS scientist Anita Pralas who is supporting the FIBREX Team presented the work of Dr. Anne Bührke in a poster session, which was nominated for the DGK poster award. Besides this, we had the opportunity to gain insight into current development pipelines of big pharma during several industry sponsored sessions, as well as to discuss their positions regarding the potential of non-coding RNA therapeutics for the treatment of CVD. Overall, our visit to the DGK 2023 in Mannheim was both enriching and rewarding.

Stay tuned for an update!

Stay tuned for an update!

Stay tuned for an update!

Stay tuned for an update!

Stay tuned for an update!

Stay tuned for an update!